Jian-Xin Jiang

Jian-Xin Jiang

Auto-generated profile, based on publicly available information

Jian-Xin Jiang

Research Institute of Surgery, Daping Hospital, Chongqing 400042, China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2018 in Cell Host & Microbe
Verified
Journal Article
Closed access
RKRui Kang
Rui Kang
LZLing Zeng
Ling Zeng
SZShan Zhu
Shan Zhu
YXYangchun Xie
Yangchun Xie
JLJiao Liu
Jiao Liu
DTDaolin Tang
Daolin Tang

25 October 2016 in Nature Communications
Verified
Journal Article
Open access
MXMin Xie
Min Xie
YYYan Yu
Yan Yu
RKRui Kang
Rui Kang
SZShan Zhu
Shan Zhu
LYLiangchun Yang
Liangchun Yang
DTDaolin Tang
Daolin Tang
Sepsis, severe sepsis and septic shock are the main cause of mortality in non-cardiac intensive care units. Immunometabolism has been linked to sepsis; however, the precise mechanism by which metabolic reprogramming regulates the inflammatory response is unclear. Here we show that aerobic glycolysis contributes to sepsis by modulating inflammasome activation in macrophages. PKM2-mediated glycolysis promotes inflammasome activation by modulating EIF2AK2 phosphorylation in macrophages. Pharmacological and genetic inhibition of PKM2 or EIF2AK2 attenuates NLRP3 and AIM2 inflammasomes activation, and consequently suppresses the release of IL-1β, IL-18 and HMGB1 by macrophages. Pharmacological inhibition of the PKM2–EIF2AK2 pathway protects mice from lethal endotoxemia and polymicrobial sepsis. Moreover, conditional knockout of PKM2 in myeloid cells protects mice from septic death induced by NLRP3 and AIM2 inflammasome activation. These findings define an important role of PKM2 in immunometabolism and guide future development of therapeutic strategies to treat sepsis.

5 March 2020 in Cell Host & Microbe
Verified
Journal Article
Closed access
HZHui Zhang
Hui Zhang
LZLing Zeng
Ling Zeng
MXMin Xie
Min Xie
JLJiao Liu
Jiao Liu
BZBorong Zhou
Borong Zhou
DTDaolin Tang
Daolin Tang

3 May 2019 in Science Advances
Verified
Journal Article
Open access
PDF file
RCRuochan Chen
Ruochan Chen
LZLing Zeng
Ling Zeng
SZShan Zhu
Shan Zhu
JLJiao Liu
Jiao Liu
HZHerbert J. Zeh
Herbert J. Zeh
RKRui Kang
Rui Kang
The ability of cytosolic lipopolysaccharide (LPS) to activate caspase-11–dependent nonclassical inflammasome is intricately controlled to avoid excessive inflammatory responses. However, very little is known about the regulatory role of various metabolic pathways in the control of caspase-11 activation. Here, we demonstrate that l-adrenaline can act on receptor ADRA2B to inhibit the activation of the caspase-11 inflammasome by cytosolic LPS or Escherichia coli infection in macrophages. l-adrenaline–induced cAMP production via the enzyme ADCY4 promotes protein kinase A (PKA) activation, which then blocks the caspase-11–mediated proteolytic maturation of interleukin-1β, gasdermin D (GSDMD) cleavage, and consequent DAMP release. Inhibition of PDE8A-mediated cAMP hydrolysis limits caspase-11 inflammasome activation and pyroptosis in macrophages. Consequently, pharmacological modulation of the ADRA2B-ADCY4-PDE8A-PKA axis, knockout of caspase-11 (Casp11−/−), or Gsdmd inactivation (GsdmdI105N/I105N) similarly protects against LPS-induced lethality in poly(I:C)-primed mice. Our results provide previously unidentified mechanistic insight into immune regulation by cAMP and represent a proof of concept that immunometabolism constitutes a potential therapeutic target in sepsis.

29 December 2021 in Autophagy
Verified
Journal Article
Open access
JLJiao Liu
Jiao Liu
SZShan Zhu
Shan Zhu
LZLing Zeng
Ling Zeng
JLJingbo Li
Jingbo Li
DKDaniel J. Klionsky
Daniel J. Klionsky
RKRui Kang
Rui Kang
Ferroptosis is a form of inflammatory cell death for which key mediators remain obscure. Here, we report that the proteoglycan decorin (DCN) is released by cells that are dying from ferroptosis and then acts as an alarm signal to trigger innate and adaptive immune responses. The early release of DCN during ferroptosis is an active process that involves secretory macroautophagy/autophagy and lysosomal exocytosis. Once released, extracellular DCN binds to the receptor advanced glycosylation end-product-specific receptor (AGER) on macrophages to trigger the production of pro-inflammatory cytokines in an NFKB/NF-κB-dependent manner. Pharmacological and genetic inhibition of the DCN-AGER axis protects against ferroptotic death-related acute pancreatitis and limits the capacity of ferroptotic cancer cells to induce a tumor-protective immune response. Thus, DCN is an essential mediator of the inflammatory and immune consequences of ferroptosis.

18 October 2017 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
LZLing Zeng
Ling Zeng
RKRui Kang
Rui Kang
SZShan Zhu
Shan Zhu
XWXiao Wang
Xiao Wang
LCLizhi Cao
Lizhi Cao
DTDaolin Tang
Daolin Tang
FDA-approved ALK-inhibiting drugs protect mice against sepsis through attenuating STING signaling activation in innate immune cells.